leadf
logo-loader
viewAG Barr

AG Barr upbeat as full-year profit slightly ahead of expectations

Revenues for the financial year ended 25 January is expected to be 9% lower at £255mln, while adjusted profit before tax was “just ahead of” £37mln

AG Barr - AG Barr confident as full-year profit slightly ahead of expectations

AG Barr PLC (LON:BAG) jumped as it announced it ended 2019 “with encouraging trading momentum” that it expects to continue into 2020.

It was a change in tone for the FTSE 250-listed Irn Bru producer, which added revenues for the financial year ended 25 January will be 9% lower at £255mln.

Volumes were hit by an increase in average price as the soft drinks company adjusted its promotional and pricing position to align with the market. 

Adjusted profit before tax was “just ahead of” £37mln, which was at the “top end” of market estimates.

It was 2.3% higher than Bloomberg consensus of £36.2mln.

The figure factors in exceptional costs of £1.5mln to £2mln to remove a wind turbine at its Cumbernauld site near Glasgow, as part of a re-engineering programme.

Deposit return scheme looms

Analysts at Liberum now expect an update on a Scottish initiative that will see consumers paying a 20p deposit when they buy bottles and cans, to get it back when they recycle.

“While we love its iconic brand portfolio and the long-term focus of the management team, we continue to factor in what should be a painful Scottish deposit return scheme,” analysts at the broker said in a note.

The company included it as a “new principal risk” in an update published last April.

Shares were up 15% to 623p on Tuesday morning.

Quick facts: AG Barr

Price: 471.5 GBX

LSE:BAG
Market: LSE
Market Cap: £528.22 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Amryt Pharma presents at the Proactive One2One virtual conference

Amryt Pharma's LON:AMYT) Rory Nealon presents at the Proactive One2One virtual conference. Amryt Pharma is a commercial stage pharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of people with rare and orphan diseases. The company...

1 day, 11 hours ago

2 min read